Literature DB >> 10984273

Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3.

R C Baxter1, A J Butt, L J Schedlich, J L Martin.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10984273     DOI： 10.1016/s1096-6374(00)90004-2

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN： 1096-6374            Impact factor:   2.372


× No keyword cloud information.
  9 in total

1.  Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Lei Zhao; Li-Ru He; Rui Zhang; Mu-Yan Cai; Yi-Ji Liao; Dong Qian; Mian Xi; Yi-Xin Zeng; Dan Xie; Meng-Zhong Liu
Journal:  Med Oncol       Date:  2011-12-14       Impact factor: 3.064

2.  IGFBP3 polymorphisms and risk of esophageal cancer in a Chinese population.

Authors:  Chao Liu; Weifeng Tang; Shuchen Chen; Yafeng Wang; Hao Qiu; Jun Yin; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families.

Authors:  Patrizia Pasanisi; Eleonora Bruno; Elisabetta Venturelli; Siranoush Manoukian; Monica Barile; Bernard Peissel; Clelia De Giacomi; Bernardo Bonanni; Jacopo Berrino; Franco Berrino
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

Review 4.  Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review.

Authors:  Roberto Bogarin; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2009-01-14       Impact factor: 1.475

Review 5.  Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.

Authors:  Kevin C J Yuen; Anthony P Heaney; Vera Popovic
Journal:  Endocrine       Date:  2016-01-05       Impact factor: 3.633

6.  Age- and gender-associated changes in the concentrations of serum TGF-1β, DHEA-S and IGF-1 in healthy captive baboons (Papio hamadryas anubis).

Authors:  E L Willis; R F Wolf; G L White; D McFarlane
Journal:  Gen Comp Endocrinol       Date:  2013-10-23       Impact factor: 2.822

7.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and prostate cancer: correlation with Gleason score.

Authors:  Livia L Correa; Leonardo Vieira Neto; Giovanna A Balarini Lima; Rafael Gabrich; Luiz Carlos D de Miranda; Monica R Gadelha
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

8.  Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas.

Authors:  Temitope O Keku; Robert S Sandler; James G Simmons; Joseph Galanko; John T Woosley; Michelle Proffitt; Oluwaseun Omofoye; Maya McDoom; Pauline K Lund
Journal:  BMC Cancer       Date:  2008-05-22       Impact factor: 4.430

9.  Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer.

Authors:  Yuefeng Du; Qingzhi Long; Ying Shi; Xiaogang Liu; Xudong Li; Jin Zeng; Yongguang Gong; Lei Li; Xinyang Wang; Dalin He
Journal:  Oncol Rep       Date:  2015-08-13       Impact factor: 3.906
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.